Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Global Prospective observationAl Study of Real-worlD managemEnt of patieNts With atrIal fibrillAtion at High Risk of Stroke (GARDENIA)

NCT05421533 is registered in ClinicalTrials.gov with Anthos Therapeutics, Inc. as lead sponsor.

NCT NCT05421533
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05421533 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Global Prospective observationAl Study of Real-worlD managemEnt of patieNts With atrIal fibrillAtion at High Risk of Stroke (GARDENIA)
Lead sponsor
Anthos Therapeutics, Inc.
Phase
Observational
Overall status
Terminated
Start date
September 14, 2022
Completion date
September 30, 2024
Enrollment
705 (actual)
Sites
96

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation